BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 32411012)

  • 1. Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.
    Momtaz S; Memariani Z; El-Senduny FF; Sanadgol N; Golab F; Katebi M; Abdolghaffari AH; Farzaei MH; Abdollahi M
    Front Physiol; 2020; 11():361. PubMed ID: 32411012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases.
    Zheng Q; Huang T; Zhang L; Zhou Y; Luo H; Xu H; Wang X
    Front Aging Neurosci; 2016; 8():303. PubMed ID: 28018215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin-proteasome system in neurodegeneration.
    McKinnon C; Tabrizi SJ
    Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
    Petrucelli L; Dawson TM
    Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response.
    Bendotti C; Marino M; Cheroni C; Fontana E; Crippa V; Poletti A; De Biasi S
    Prog Neurobiol; 2012 May; 97(2):101-26. PubMed ID: 22033150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular functions regulated by deubiquitinating enzymes in neurodegenerative diseases.
    Do HA; Baek KH
    Ageing Res Rev; 2021 Aug; 69():101367. PubMed ID: 34023421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
    Moore DJ; Dawson VL; Dawson TM
    Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
    Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin proteasome system in glia and its role in neurodegenerative diseases.
    Jansen AH; Reits EA; Hol EM
    Front Mol Neurosci; 2014; 7():73. PubMed ID: 25152710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-Proteasome System in Neurodegenerative Disorders.
    Rao G; Croft B; Teng C; Awasthi V
    J Drug Metab Toxicol; 2015; 6(4):. PubMed ID: 30761219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.
    Potjewyd FM; Axtman AD
    Front Cell Neurosci; 2021; 15():768655. PubMed ID: 34867205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.
    Liang Y; Zhong G; Ren M; Sun T; Li Y; Ye M; Ma C; Guo Y; Liu C
    Neuromolecular Med; 2023 Dec; 25(4):471-488. PubMed ID: 37698835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System.
    Staszczak M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. We Are What We Eat: Ubiquitin-Proteasome System (UPS) Modulation Through Dietary Products.
    Panagiotidou E; Chondrogianni N
    Adv Exp Med Biol; 2020; 1233():329-348. PubMed ID: 32274765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein clearance strategies for disease intervention.
    Hommen F; Bilican S; Vilchez D
    J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.